Effects of Combining PNF With NMES in Young Football Players
Launched by CARDENAL HERRERA UNIVERSITY · Jul 11, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how two different stretching methods might help improve hamstring flexibility and jumping ability in young football players. Hamstring injuries are common in football and can keep players from training or playing for a long time. In this study, one group of players will do a special type of stretching called PNF (proprioceptive neuromuscular facilitation) combined with a treatment called NMES (neuromuscular electrical stimulation), which uses gentle electrical pulses to help muscles work better. The other group will do the same stretching but with a fake (placebo) version of the electrical stimulation to see if the real treatment makes a difference.
Young football players between the ages of 10 and 18 who train at least three times a week may be eligible to join. However, players currently doing a regular hamstring stretching program, those with recent hamstring injuries, low back pain, or recent surgeries on their back or abdomen won’t be able to participate. If you join, you’ll follow the stretching routines and receive either the real or fake electrical stimulation while your flexibility and jumping skills are measured. This study aims to find safer and more effective ways to keep young athletes active and reduce the risk of hamstring injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Active football players who train at least 3 days a week.
- • Ages between 10 and 18 years.
- Exclusion Criteria:
- • Are currently engaged in a structured hamstring-stretching programme.
- • Present with acute low back pain.
- • Have sustained a hamstring injury within the past 6 months.
- • Have undergone spinal or abdominal surgery within the past 6 months.
About Cardenal Herrera University
Cardenal Herrera University is a leading academic institution dedicated to advancing healthcare research and education. With a strong emphasis on interdisciplinary collaboration, the university fosters innovative clinical trials aimed at improving patient outcomes and enhancing medical practices. Its commitment to ethical research practices, coupled with a robust network of healthcare professionals and researchers, positions Cardenal Herrera University as a key contributor to the development of evidence-based solutions in the medical field. Through its clinical trial sponsorship, the university aims to bridge the gap between research and clinical application, ultimately benefiting the broader healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alfara Del Patriarca, Valencia, Spain
Patients applied
Trial Officials
Juan Francisco Lisón Párraga, Dr
Principal Investigator
Cardenal Herrera University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported